Position in EVGN
as of Mar 31, 2026
· filed Apr 10, 2026
Position Value
$7,381
-$3,163 QoQ
Shares Held
9,586
0.0% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EVGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Daytona Street Capital LLC holds $1,529,388 across 7 Biotechnology names. EVGN ranks #5 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DRTS |
Alpha Tau Medical Ltd.
|
146,106 | $1,032,969 | |
| 2 | ELDN |
Eledon Pharmaceuticals, Inc.
|
81,166 | $249,991 | |
| 3 | OBIO |
Orchestra BioMed Holdings, Inc.
|
52,600 | $223,550 | |
| 4 | MAIA |
MAIA Biotechnology, Inc.
|
7,500 | $10,500 | |
| 5 | EVGN |
Evogene Ltd.
This page
|
9,586 | $7,381 | |
| 6 | INCY |
Incyte Corp
|
45 | $4,235 | |
| 7 | MRNA |
Moderna, Inc.
|
15 | $762 |
All Filings in EVGN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,381 | 9,586 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $10,544 | 9,586 | Shares | Sole | 2026-01-21 | |
| No filing history on record for this holder in this stock. | ||||||